盤中異動 | 騰盛博藥-B盤中上漲8%,報於8.3港元
2022年12月21日9時44分,騰盛博藥-B(HK02137)盤中上漲8%,報於8.3港元,成交額達1542.01萬港元,換手率達到0.01%。
12月15日訊,騰盛博藥-B(02137)公佈,於2022年12月15日,公司根據首次公開發售後購股權計劃條款向10名購股權受讓人授出合共149.7萬份購股權,惟須待購股權受讓人接納。購股權的行使價爲每股股份8.64港元,有效期10年。同日,公司根據首次公開發售後股份獎勵計劃條款自願向10位受限制股份單位受讓人以零代價授出合共39.65萬份受限制股份單位,惟須待彼等接納。
盈立趨勢長盈模型最近一次交易信號,2022年12月5日出現關注信號,觸發價格爲9.09港元(信號僅供參考)。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.